GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (Q38312497)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2000

Language	Label	Description	Also known as
English	GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology	scientific article published on February 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

0 references

Prader–Willi syndrome

1 reference

based on heuristic

inferred from title

author name string

Corrias A

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Bellone J

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Beccaria L

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Bosio L

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Trifirò G

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Livieri C

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ragusa L

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Salvatoni A

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Andreo M

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ciampalini P

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Tonini G

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Crinò A

12

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

84-89

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Inter- and intrachromosomal rearrangements are both involved in the origin of 15q11-q13 deletions in Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

The Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Free insulin-like growth factors in human obesity.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Impaired growth hormone secretion in the adult population: relation to age and adiposity

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation

1 reference

https://api.crossref.org/works/10.1007%2FBF03343684

21 January 2018

Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prader-Willi syndrome: consensus diagnostic criteria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method for assessing age-standardized weight-for-height in children seen cross-sectionally

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of growth hormone releasing hormone in obese children

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone secretion in Prader-Willi syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone secretion in Prader-Willi syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma growth hormone response to oral clonidine as compared to insulin hypoglycemia in obese children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deletions of chromosome 15 as a cause of the Prader-Willi syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10800760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03343684

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38312497&oldid=2201552805"